Glaxosmithkline Pharmaceuticals consolidated net profit rises 12.44% in the June 2025 quarter
Sales decline 1.16% to Rs 805.17 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 12.44% to Rs 205.01 crore in the quarter ended June 2025 as against Rs 182.33 crore during the previous quarter ended June 2024. Sales declined 1.16% to Rs 805.17 crore in the quarter ended June 2025 as against Rs 814.65 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales805.17814.65 -1 OPM %31.2028.30 -PBDT294.50265.81 11 PBT278.98249.40 12 NP205.01182.33 12Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content